Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...
A rise in popularity in glucagon-like peptide 1 receptor agonists such as Ozempic and Wegovy is causing concern in the medical community over potential side effects for various physician specialties, ...
This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...
Discover how antibody-drug conjugates (ADCs) are transforming treatment strategies for gastrointestinal cancers, enhancing ...
Everyday Health on MSN
Do oral GLP-1 drugs work as well as injectables? We checked the science
FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.
A large cohort study found three popular GLP-1-based diabetes drugs -- semaglutide, dulaglutide, and tirzepatide -- carry similar risks for serious adverse GI events, with a rate of about 12 per 1,000 ...
Lawsuits filed against the manufacturers of Ozempic, Mounjaro, and other weight control and diabetes drugs have alleged that these medications can cause serious gastrointestinal side effects, ...
Patients who used aspirin, NSAIDs or anti-clotting drugs prior to a GI procedure did not have an increased bleeding risk, according to research presented at the American College of Gastroenterology’s ...
Researchers report that GLP-1 drugs prescribed for weight loss, like Ozempic and Mounjaro, may improve cognition and lower dementia and cardiovascular disease risk. However, they also found that GLP-1 ...
Ducharme is a contributor to TIME. Ducharme is a contributor to TIME. In 2021, Jacqueline Barber agreed to try Ozempic because her doctor swore it would “work wonders” for her diabetes. A few months ...
Capecitabine is an oral chemotherapy used to treat many gastrointestinal cancers. Its complex dosing and narrow therapeutic index make medication adherence and toxicity management crucial for quality ...
Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results